DIACCURATE Trademark

Trademark Overview

On Monday, December 20, 2021, a trademark application was filed for DIACCURATE with the United States Patent and Trademark Office. The USPTO has given the DIACCURATE trademark a serial number of 79332477. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by DIACCURATE. The DIACCURATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations for use in human and animal health, namely, for the treatment of cancer; pharmaceutical preparations for the treatment of human and animal health diseases, disorders and conditions in the nature of gynecological, obstetric, digestive, neurological and brain, breast, and digestive diseases, disorders and conditions; pharmaceutical preparations for the treatment of women's health diseases, disorders and conditions in the nature of gynecological, obstetric, neurological and brain, breast, and digestive diseases, disorders and conditions; biological preparations and compounds for use in the treatment of cancer; anti-cancer medicines; non-steroidal anti-inflammatory medicines; antiviral medicines for HIV treatment
diaccurate

General Information

Serial Number79332477
Word MarkDIACCURATE
Filing DateMonday, December 20, 2021
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7171716
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations for use in human and animal health, namely, for the treatment of cancer; pharmaceutical preparations for the treatment of human and animal health diseases, disorders and conditions in the nature of gynecological, obstetric, digestive, neurological and brain, breast, and digestive diseases, disorders and conditions; pharmaceutical preparations for the treatment of women's health diseases, disorders and conditions in the nature of gynecological, obstetric, neurological and brain, breast, and digestive diseases, disorders and conditions; biological preparations and compounds for use in the treatment of cancer; anti-cancer medicines; non-steroidal anti-inflammatory medicines; antiviral medicines for HIV treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDIACCURATE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameDIACCURATE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameDIACCURATE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Monday, January 22, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 28, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 28, 2023FINAL DISPOSITION PROCESSED
Tuesday, December 26, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Monday, July 10, 2023NOTIFICATION PROCESSED BY IB
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, June 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 21, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, June 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 6, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, June 6, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 25, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 25, 2023FINAL REFUSAL E-MAILED
Tuesday, April 25, 2023FINAL REFUSAL WRITTEN
Wednesday, April 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 28, 2022REFUSAL PROCESSED BY IB
Wednesday, December 7, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 7, 2022REFUSAL PROCESSED BY MPU
Tuesday, September 27, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 26, 2022NON-FINAL ACTION WRITTEN
Monday, September 26, 2022ASSIGNED TO EXAMINER
Tuesday, February 8, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

diaccurate treatment preparations pharmaceutical diseases conditions cancer disorders medicines health digestive